We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...

Shares of Charles River Laboratories International Inc. CRL rose 1.73% to $106.05 Thursday, on what proved to be an ...

Jamie Jacobs, SVP at the Natick staffing firm TalentBurst, says "about half" of life sciences companies remain committed to DEI. "Now we’re seeing who was actually serious about it, and who’s not.” ...

Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares.

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Raja Chatterjee has joined the Company's Risk, ...

The S&P 500 gained 0.8% on Monday, April 14, 2025, after smartphones and other electronics were exempted from President ...

The Alamogordo chimpanzees, many in their 50s and 60s, were the last remaining at the facility due to their age and fragility ...

Shares of Apple and Tesla have lost more than 10% since “Liberation Day” during the stock market rollercoaster.

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

Charles River Labs faces a 60% loss due to reduced R&D spending, FDA's phase-out of animal testing, and increased competition ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...